Mid-Year Oncology Review 2025: History Informs the Future

What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.

Ipsos Mid Year Oncology Review 2025 - History Informs the FutureIpsos explores challenges and opportunities in the development of emerging therapeutic modalities aimed at addressing solid tumors as well as prominent topics in the field including the dominance of small molecules as a time-tested and well-established modality that nonetheless continues to lead in FDA approval numbers each year; the potential of cancer vaccines to break through to the forefront owing to the opportunities created by mRNA-based neoantigens; and the journey of cell therapies as they start to penetrate solid tumor applications. 

In this white paper, supported by Ipsos’ survey of oncologists based in the US, as well as KOL interviews, we reveal 5 key themes in oncology and how past lessons inform the innovations of today.

Sign up to access the white paper

The author(s)

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights
    Artificial Intelligence (AI) Events replay

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.